BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  Local and National Organizations Benefit From AIT Bioscience CEO’s Leadership

  The Vanguard Forum for Healthcare Leaders invited AIT Bioscience CEO Terri Pascarelli to serve as a faculty member at its November 2017 event in New York City, NY.

  December 22, 2017

   · 

  2 min read
• FDA

  Bausch & Lomb Receives FDA Approval of LUMIFY

  Lumify is the only over-the-counter eye drop with low-dose brimonidine for the treatment of eye redness.

  December 22, 2017

   · 

  4 min read
• Pharm Country

  Roswell Park Research Identifies Cells that May be Responsible for Prostate Cancer Recurrence

  Although men with prostate cancer usually respond to standard treatment with hormone therapy or chemotherapy, many will eventually experience progression or recurrence despite treatment - particularly those with high-risk or aggressive forms of the disease.

  December 22, 2017

   · 

  2 min read
• BioCapital

  FDA Updates the Label of Tasigna to Reflect That Certain Patients With a Type of Leukemia May Bb Eligible to Stop Treatment After Sustained Response

  The FDA today updated the product label for the cancer drug Tasigna to include information for providers about how to discontinue the drug in certain patients.

  December 22, 2017

   · 

  6 min read
• BioMidwest

  American Society of Mass Spectrometry in Indy

  From June 4-8, the city of Indianapolis had the privilege of playing host to nearly 6500 scientists from around the world who gathered to discuss all aspects of using mass spectrometry in a wide variety of applications.

  December 22, 2017

   · 

  1 min read
• BioMidwest

  AIT Bioscience Attends Bio+Tech17 and AAPS NBC Conferences

  AIT Biosciences recently attended the Bio+Tech17 Conference in Bethesda, Maryland from April 27-28, 2017 and the AAPS NBC Conference in San Diego, California from May 1-3, 2017.

  December 22, 2017

   · 

  1 min read
• BioMidwest

  AIT Bioscience Recognized with Awards at Recent WRIB

  WRIB (Workshop for Recent Issues in Bioanalysis) is an annual gathering of bioanalytical scientists from across the pharmaceutical industry spectrum.

  December 22, 2017

   · 

  2 min read
• BioMidwest

  AIT Bioscience Offers New Screening Level Assay

  A fit-for-purpose approach to bioanalytical assay support balances intended use of data with regulatory requirements and budgets.

  December 22, 2017

   · 

  1 min read
• Policy

  QIAGEN to Take Impairment on Deferred Tax Assets, Informs on Expected Impacts of New U.S. Tax Law and Other Changes in Global Tax Environment

  QIAGEN N.V.announces that, mainly as a consequence of the new U.S. tax legislation, it will take an after-tax charge on net income of approximately $110-120 million (or about $0.47-$0.52 per share) in the fourth quarter of 2017.

  December 22, 2017

   · 

  1 min read
• 

  Policy

  SEC Subpoenas Massachusetts’ Ocular Therapeutix Over Pain Relief Implant

  The Company denies any allegations of wrongdoing and intends to vigorously defend against these lawsuits.

  December 22, 2017

   · 

  7 min read